Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects

• Váldodahkkit: Maria Isabel Ramos Saraiva (Dahkki), Larissa Karine Leite Portocarrero (Dahkki), Marcella Amaral Horta Barbosa Vieira (Dahkki), Bethania Cabral Cavalli Swiczar (Dahkki), Andrezza Telles Westin (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Sociedade Brasileira de Dermatologia, 2018-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract: Background: Actinic keratoses are benign intraepithelial skin neoplasms that develop in photoexposed areas and can progress to invasive carcinoma. They are seen frequently in dermatological practice, occurring in 5.1% of consultations. Ingenol mebutate (IM) was recently approved in Brazil...